MENLO PARK, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences”), an eyecare technology company focused on developing and commercializing innovative ...

Alcon issued a global recall of CyPass Micro-Stent and advised surgeons to immediately stop implanting the device in patients after reviewing long-term safety data, Verdict Medical Devices reports. 1.

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Glaukos has claimed a series of regulatory clearances in Europe for its micro-scale surgical implants to treat patients with glaucoma, expanding the company’s reach overseas. The green lights under ...

John A. Moran Eye Center alumnus Iqbal "Ike" Ahmed, MD, FRCSC, will tell you he is not afraid of controversy. "Challenge the norm. Challenge what we do…but do it respectfully," Ahmed advised residents ...

Ophthalmic research focus grows around glaucoma therapy and device development Webinar spotlight covers BL therapy and ELIOS surgical platform technology Sector discussion expands alongside activity ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal ...

Glaukos pioneered Micro-Invasive Glaucoma Surgery (MIGS), which involves insertion of a micro-scale device from within the eye's anterior chamber through a small corneal incision. Glaukos’ MIGS ...

Please provide your email address to receive an email when new articles are posted on . I was honored to give the Stephen A. Obstbaum, MD, Lecture at the 2022 American Society of Cataract and ...